Cargando…

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

INTRODUCTION: PolycombGroup (PcG) proteins maintain gene repression through histone modifications and have been implicated in stem cell regulation and cancer. EZH2 is part of Polycomb Repressive Complex 2 (PRC2) and trimethylates H3K27. This histone mark recruits the BMI1-containing PRC1 that silenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietersen, Alexandra M, Horlings, Hugo M, Hauptmann, Michael, Langerød, Anita, Ajouaou, Abderrahim, Cornelissen-Steijger, Paulien, Wessels, Lodewijk F, Jonkers, Jos, Vijver, Marc J van de, van Lohuizen, Maarten
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656906/ https://www.ncbi.nlm.nih.gov/pubmed/19099573 http://dx.doi.org/10.1186/bcr2214

Ejemplares similares

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
por: Puppe, Julian, et al.
Publicado: (2009)

Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
por: Koppens, Martijn AJ, et al.
Publicado: (2016)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
por: Holstege, Henne, et al.
Publicado: (2010)

GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors
por: Westerman, Bart A., et al.
Publicado: (2012)

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
por: Steele, J C, et al.
Publicado: (2006)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
por: Ratz, Leonie, et al.
Publicado: (2022)

Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice
por: Oguro, Hideyuki, et al.
Publicado: (2006)

Computational identification of insertional mutagenesis targets for cancer gene discovery
por: de Jong, Johann, et al.
Publicado: (2011)

A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition
por: Gisler, Santiago, et al.
Publicado: (2020)

Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities
por: Serresi, Michela, et al.
Publicado: (2018)

TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer
por: Versemann, Lennart, et al.
Publicado: (2022)

A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
por: Batenburg, Kevin L., et al.
Publicado: (2023)

Neuron-Glia Interactions Increase Neuronal Phenotypes in Tuberous Sclerosis Complex Patient iPSC-Derived Models
por: G. Nadadhur, Aishwarya, et al.
Publicado: (2018)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition
por: Jin, Xun, et al.
Publicado: (2017)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Integration of Clinical and Gene Expression Data Has a Synergetic Effect on Predicting Breast Cancer Outcome
por: van Vliet, Martin H., et al.
Publicado: (2012)

Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter
por: Leferink, Prisca S., et al.
Publicado: (2019)

Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability
por: van Vliet, Martin H, et al.
Publicado: (2008)

Applications of DNA integrating elements: Facing the bias bully
por: de Jong, Johann, et al.
Publicado: (2015)

TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development
por: Cornelissen, Lisette M., et al.
Publicado: (2020)

The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
por: Zhai, Run, et al.
Publicado: (2016)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Enhancer of Zeste Homolog 2 (EZH2) Contributes to Rod Photoreceptor Death Process in Several Forms of Retinal Degeneration and Its Activity Can Serve as a Biomarker for Therapy Efficacy
por: Mbefo, Martial, et al.
Publicado: (2021)

Analysis of Tumor Heterogeneity and Cancer Gene Networks Using Deep Sequencing of MMTV-Induced Mouse Mammary Tumors
por: Klijn, Christiaan, et al.
Publicado: (2013)

The Polycomb Protein and E3 Ubiquitin Ligase Ring1B Harbors an IRES in its Highly Conserved 5′ UTR
por: Boutsma, Erwin, et al.
Publicado: (2008)

DNA Methyltransferase Controls Stem Cell Aging by Regulating BMI1 and EZH2 through MicroRNAs
por: So, Ah-Young, et al.
Publicado: (2011)

EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c
por: Xu, Leibo, et al.
Publicado: (2020)

XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
por: Kluin, Roelof J. C., et al.
Publicado: (2018)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
por: Vonlanthen, S, et al.
Publicado: (2001)

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets
por: Lai, Carmen, et al.
Publicado: (2007)

Large-Scale Mutagenesis in p19(ARF)- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks
por: Uren, Anthony G., et al.
Publicado: (2008)

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
por: Langerød, Anita, et al.
Publicado: (2007)

Childhood BMI is inversely associated with pubertal timing in normal-weight but not overweight boys
por: Bygdell, Maria, et al.
Publicado: (2018)

Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
por: Benard, Anne, et al.
Publicado: (2014)

SUMOylation of DRIL1 Directs Its Transcriptional Activity Towards Leukocyte Lineage-Specific Genes
por: Prieur, Alexandre, et al.
Publicado: (2009)

Ruthenium-Locked Helical Chirality: A Barrier of Inversion and Formation of an Asymmetric Macrocycle
por: van de Griend, Corjan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40hidq0uhbt0pdohsdd44qsbn5